{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:25:46Z","timestamp":1776212746549,"version":"3.50.1"},"reference-count":48,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T00:00:00Z","timestamp":1638576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004488","name":"Croatian Science Foundation","doi-asserted-by":"publisher","award":["PRE-HYPO No. IP-2018-01-1284"],"award-info":[{"award-number":["PRE-HYPO No. IP-2018-01-1284"]}],"id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Type 1 diabetes (T1DM) is an autoimmune disease characterized by the gradual loss of \u03b2-cell function and insulin secretion. In pregnant women with T1DM, endogenous insulin production is absent or minimal, and exogenous insulin is required to control glycemia and prevent ketoacidosis. During pregnancy, there is a partial decrease in the activity of the immune system, and there is a suppression of autoimmune diseases. These changes in pregnant women with T1DM are reflected by Langerhans islet enlargement and improved function compared to pre-pregnancy conditions. N-3 polyunsaturated fatty acids (n-3 PUFA) have a protective effect, affect \u03b2-cell preservation, and increase endogenous insulin production. Increased endogenous insulin production results in reduced daily insulin doses, better metabolic control, and adverse effects of insulin therapy, primarily hypoglycemia. Hypoglycemia affects most pregnant women with T1DM and is several times more common than that outside of pregnancy. Strict glycemic control improves the outcome of pregnancy but increases the risk of hypoglycemia and causes maternal complications, including coma and convulsions. The suppression of the immune system during pregnancy increases the concentration of C-peptide in women with T1DM, and n-3 PUFA supplements serve as the additional support for a rise in C-peptide levels through its anti-inflammatory action.<\/jats:p>","DOI":"10.3390\/pharmaceutics13122082","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T03:10:38Z","timestamp":1638760238000},"page":"2082","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["N-3 PUFA and Pregnancy Preserve C-Peptide in Women with Type 1 Diabetes Mellitus"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7332-5936","authenticated-orcid":false,"given":"Josip","family":"Delmis","sequence":"first","affiliation":[{"name":"Clinical Department of Obstetrics and Gynecology, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6478-1174","authenticated-orcid":false,"given":"Marina","family":"Ivanisevic","sequence":"additional","affiliation":[{"name":"Clinical Department of Obstetrics and Gynecology, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0815-3584","authenticated-orcid":false,"given":"Marina","family":"Horvaticek","sequence":"additional","affiliation":[{"name":"Institute Rudjer Boskovic, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.2337\/dci21-0043","article-title":"The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"44","author":"Holt","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1399-5448.2007.00272.x","article-title":"Effects of beta-cell rest on beta-cell function: A review of clinical and preclinical data","volume":"9","author":"Brown","year":"2008","journal-title":"Pediatric Diabetes"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2337\/dci18-0001","article-title":"Glycemic treatment during type 1 diabetes pregnancy: A story of (mostly) sweet success!","volume":"41","author":"Murphy","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/dc09-0656","article-title":"Obstetric and perinatal outcomes in type 1 diabetic pregnancies: A large, population-based study","volume":"32","author":"Persson","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000087420","article-title":"Clinical management of pregnancy complicated with type1\/type2 diabetes mellitus","volume":"Volume 17","author":"Djelmis","year":"2005","journal-title":"Diabetology of Pregnancy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1001\/jama.2019.4981","article-title":"Management of Preexisting Diabetes in Pregnancy: A Review","volume":"321","author":"Alexopoulos","year":"2019","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): A multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1464-5491.2012.03604.x","article-title":"Hypoglycaemia during pregnancy in women with type 1 diabetes","volume":"29","author":"Ringholm","year":"2012","journal-title":"Diabet. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/j.clinthera.2007.12.015","article-title":"Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus","volume":"29","author":"Kinsley","year":"2007","journal-title":"Clin. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2337\/diacare.24.8.1501","article-title":"Maternal Mortality in Type 1 Diabetes","volume":"24","author":"Leinonen","year":"2001","journal-title":"Diabetes Care"},{"key":"ref_11","first-page":"29","article-title":"Glycemic control in the diabetic pregnancy: Is tighter always better?","volume":"9","author":"Rosenn","year":"2000","journal-title":"J. Matern. Fetal Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15605\/jafes.034.01.06","article-title":"Prevalence of Hypoglycaemia among Insulin-Treated Pregnant Women with Diabetes Who Achieved Tight Glycaemic Control","volume":"34","author":"Ng","year":"2019","journal-title":"J. ASEAN Fed. Endocr. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"International Hypoglycaemia Study Group (2017). Glucose Concentrations of Less Than 3.0 mmol\/L (54 mg\/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 40, 155\u2013157.","DOI":"10.2337\/dc16-2215"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/bip.20734","article-title":"Insulin structure and function","volume":"88","author":"Mayer","year":"2007","journal-title":"Biopolymers"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rahman, S., Hossain, K.S., Das, S., Kundu, S., Adegoke, E.O., Rahman, A., Hannan, A., Uddin, J.J., and Pang, M.-D. (2021). Role of Insulin in Health and Disease: An Update. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126403"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E759","DOI":"10.1152\/ajpendo.2000.278.5.E759","article-title":"Role of C-peptide in human physiology","volume":"278","author":"Wahren","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/diabetes.53.1.250","article-title":"ADA Workshop Report: C-Peptide. Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve \u03b2-Cell Function","volume":"53","author":"Palmer","year":"2004","journal-title":"Diabetes"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/diacare.26.3.832","article-title":"Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial","volume":"26","author":"Steffes","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2337\/dc08-2326","article-title":"Preservation of beta-cell Function in auto antibody-positive youth with diabetes","volume":"32","author":"Greenbaum","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e120877","DOI":"10.1172\/jci.insight.120877","article-title":"Type 1 Diabetes TrialNet Study Group. \u03b2 Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis","volume":"3","author":"Sims","year":"2018","journal-title":"JCI Insight"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1172\/JCI130310","article-title":"Insulin: Still a miracle after all these years","volume":"129","author":"Barbetti","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s12020-015-0534-9","article-title":"Beta-cell destruction and preservation in childhood and adult-onset type 1 diabetes","volume":"49","author":"Poudel","year":"2015","journal-title":"Endocrine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1210\/jc.2016-3806","article-title":"\u03b2 Cells Persist in T1D Pancreata without Evidence of Ongoing \u03b2-Cell Turnover or Neogenesis","volume":"102","author":"Lam","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaut.2011.02.004","article-title":"Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children","volume":"37","author":"Ziegler","year":"2011","journal-title":"J. Autoimmun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1385\/CRIAI:26:3:161","article-title":"Immunology of pregnancy: Implications for the mother","volume":"26","author":"Poole","year":"2004","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e04569","DOI":"10.1016\/j.heliyon.2020.e04569","article-title":"Possible mechanisms involved in improved beta cell function in pregnant women with type 1 diabetes","volume":"19","author":"Nalla","year":"2020","journal-title":"Heliyon"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/dom.12716","article-title":"\u03b2-Cell adaptation in pregnancy","volume":"18","author":"Baeyens","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tem.2009.11.001","article-title":"Expansion of beta-cell mass in response to pregnancy","volume":"21","author":"Rieck","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"101188","DOI":"10.1016\/j.diabet.2020.04.005","article-title":"Pregnant type 1 diabetes women with rises in C-peptide display higher levels of regulatory T cells: A pilot study","volume":"47","author":"Amouyal","year":"2021","journal-title":"Diabetes Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2337\/dc08-1832","article-title":"Pregnancy-induced rise in serum C-peptide concentrations in women with type 1 diabetes","volume":"32","author":"Nielsen","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.2337\/dc21-0028","article-title":"Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism?","volume":"44","author":"Meek","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1111\/j.1464-5491.2012.03747.x","article-title":"Plasma C-peptide concentration in women with Type 1 diabetes during early and late pregnancy","volume":"29","author":"Murphy","year":"2012","journal-title":"Diabet. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1079\/BJN2002689","article-title":"Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women","volume":"88","author":"Burdge","year":"2002","journal-title":"Br. J. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1079\/PNS2005473","article-title":"Long-chain n-3 PUFA: Plant v. marine sources","volume":"65","author":"Williams","year":"2006","journal-title":"Proc. Nutr. Soc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","article-title":"Omega-3 fatty acids in inflammation and autoimmune diseases","volume":"21","author":"Simopoulos","year":"2002","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"a016311","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/ejcn.2017.46","article-title":"Effect of eicosapentaenoic acid and docosahexaenoic acid supplementation on C-peptide preservation in pregnant women with type-1 diabetes: Randomized placebo controlled clinical trial","volume":"71","author":"Horvaticek","year":"2017","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.2337\/dc12-2084","article-title":"Nutritional factors and preservation of C-peptide in youth with recently diagnosed type 1 diabetes: SEARCH Nutrition Ancillary Study","volume":"36","author":"Dabelea","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ajcn\/79.5.820","article-title":"Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction","volume":"79","author":"Chiu","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(01)06580-1","article-title":"Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study","volume":"358","author":"Reunanen","year":"2001","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s001250051530","article-title":"Is the paradoxical first trimester drop in insulin requirement due to an increase in C-peptide concentration in pregnant Type 1 diabetic women?","volume":"43","author":"Ilic","year":"2000","journal-title":"Diabetologia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/dme.13960","article-title":"Persistent C-peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: Evidence for lack of intensive treatment in UK clinical practice?","volume":"36","author":"Marren","year":"2019","journal-title":"Diabet. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e002288","DOI":"10.1136\/bmjdrc-2021-002288","article-title":"Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes","volume":"9","author":"Wellens","year":"2021","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/dme.13585","article-title":"Continuous glucose monitoring in pregnant women with Type 1 diabetes: Benefits for mothers, using pumps or pens, and their babies","volume":"35","author":"Feig","year":"2018","journal-title":"Diabet. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/ajcn\/83.6.1337","article-title":"Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: A meta-analysis of randomized controlled trials","volume":"83","author":"Szajewska","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jn\/137.4.855","article-title":"Dietary (n-3) fatty acids and brain development","volume":"137","author":"Innis","year":"2007","journal-title":"J. Nutr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1542\/peds.111.1.e39","article-title":"Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children\u2019s IQ at 4 years of age","volume":"111","author":"Helland","year":"2003","journal-title":"Pediatrics"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA) (2010). Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J., 8, 1461.","DOI":"10.2903\/j.efsa.2010.1461"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/12\/2082\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:39:49Z","timestamp":1760168389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/12\/2082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,4]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["pharmaceutics13122082"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13122082","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,4]]}}}